LY3050258

· Eli Lilly and Company

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for LY3050258, covering 2018-07-23 to 2018-07-27. Get the full timeline:

Most recent: Clinical Trial Update: A Study of LY3050258 in Healthy Participants [Phase 1]